Ferroptosis vulnerability in MYCN‐driven neuroblastomas

Ferroptosis vulnerability in MYCN‐driven neuroblastomas

Bibliographic Details
Main Authors:	Shayani Dasgupta, Boyi Gan
Format:	Article
Language:	English
Published:	Wiley 2022-08-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.963

Similar Items

MYCN and Metabolic Reprogramming in Neuroblastoma
by: Mohit Bansal, et al.
Published: (2022-08-01)

Metastasis in neuroblastoma: the MYCN question
by: Swapnil Parashram Bhavsar
Published: (2023-05-01)

LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
by: Hamed Alborzinia, et al.
Published: (2023-08-01)

MYCN in Neuroblastoma: “Old Wine into New Wineskins”
by: Maria Braoudaki, et al.
Published: (2021-10-01)

A chemo-genomic approach identifies diverse epigenetic therapeutic vulnerabilities in MYCN-amplified neuroblastoma
by: Krstic, A, et al.
Published: (2021)

Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma
by: Lei Zhai, et al.
Published: (2023-10-01)

Epigenetic Dysregulation in <i>MYCN</i>-Amplified Neuroblastoma
by: Soraya Epp, et al.
Published: (2023-12-01)

<i>MYCN</i> Amplifications and Metabolic Rewiring in Neuroblastoma
by: Marialena Pouliou, et al.
Published: (2023-09-01)

The potential molecularly therapy target to MYCN‐amplificated neuroblastoma
by: Susu Jiang, et al.
Published: (2023-08-01)

SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
by: Kezhe Tan, et al.
Published: (2022-12-01)

CCNB1IP1 prevents ubiquitination‐mediated destabilization of MYCN and potentiates tumourigenesis of MYCN‐amplificated neuroblastoma
by: Yang Zhou, et al.
Published: (2023-07-01)

MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma
by: Tao Liu, et al.
Published: (2022-11-01)

Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
by: Anders Valind, et al.
Published: (2023-12-01)

MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
by: Jinqiu Guan, et al.
Published: (2024-02-01)

Adaptation of the Th-MYCN Mouse Model of Neuroblastoma for Evaluation of Disseminated Disease
by: Seyed M. Rahavi, et al.
Published: (2023-07-01)

Deficiency of BAP1 inhibits neuroblastoma tumorigenesis through destabilization of MYCN
by: Xiaoling Zhang, et al.
Published: (2023-08-01)

Ceftriaxone exerts antitumor effects in MYCN‐driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression
by: Pamorn Chittavanich, et al.
Published: (2024-04-01)

A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma
by: Laura D. Gamble, et al.
Published: (2021-04-01)

Lack of Homozygously Inactivated p73 in Single-Copy MYCN Primary Neuroblastomas and Neuroblastoma Cell Lines
by: Xiao-Tang Kong, et al.
Published: (1999-04-01)

MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation
by: Jolien De Wyn, et al.
Published: (2021-09-01)

MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
by: Damiano Bartolucci, et al.
Published: (2022-09-01)

Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.
by: Candy Kumps, et al.
Published: (2013-01-01)

Genetic variation associated with childhood and adult stature and risk of MYCN‐amplified neuroblastoma
by: Eleanor C. Semmes, et al.
Published: (2020-11-01)

Correction: Aryl Hydrocarbon Receptor Downregulates MYCN Expression and Promotes Cell Differentiation of Neuroblastoma
Published: (2014-01-01)

Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN
by: Steffen Fuchs, et al.
Published: (2023-07-01)

Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry
by: Abraham, Brian J., et al.
Published: (2020)

Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
by: Amparo López-Carrasco, et al.
Published: (2020-10-01)

Targeting bromodomain and extra-terminal proteins to inhibit neuroblastoma tumorigenesis through regulating MYCN
by: Xiyao Shi, et al.
Published: (2022-09-01)

CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
by: Gross, N, et al.
Published: (1994)

Single-Cell Gene Network Analysis and Transcriptional Landscape of MYCN-Amplified Neuroblastoma Cell Lines
by: Daniele Mercatelli, et al.
Published: (2021-01-01)

LncRNA AC142119.1 facilitates the progression of neuroblastoma by epigenetically initiating the transcription of MYCN
by: Rui Yang, et al.
Published: (2023-09-01)

Diagnostic value of CT and MRI combined with serum LDH, NSE, CEA, and MYCN in pediatric neuroblastoma
by: Jumei Hao, et al.
Published: (2023-08-01)

Extracellular Vesicle-Based Method for Detecting <i>MYCN</i> Amplification Status of Pediatric Neuroblastoma
by: Jirawan Panachan, et al.
Published: (2022-05-01)

Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment
by: Carolina Rosswog, et al.
Published: (2017-12-01)

Critical Role for GAB2 in Neuroblastoma Pathogenesis through the Promotion of SHP2/MYCN Cooperation
by: Xiaoling Zhang, et al.
Published: (2017-03-01)

Ferroptosis hijacking by Mycobacterium tuberculosis
by: Boyi Gan
Published: (2023-03-01)

Optimal combination of MYCN differential gene and cellular senescence gene predicts adverse outcomes in patients with neuroblastoma
by: Jiaxiong Tan, et al.
Published: (2023-11-01)

The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN
by: Kiyohiro Ando, et al.
Published: (2023-02-01)

Aryl hydrocarbon receptor is a tumor promoter in MYCN-amplified neuroblastoma cells through suppression of differentiation
by: Kanita A. Chaudhry, et al.
Published: (2023-11-01)

ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry
by: Durbin, Adam D., et al.
Published: (2020)